Review ArticleBrace treatment in adolescent idiopathic scoliosis: risk factors for failure—a literature review
Keywords
Cited by (0)
FDA device/drug status: Not applicable.
Author disclosures: REH: Payment for Writing or Reviewing the Manuscript: ApiFix Ltd. (B); Consulting: ApiFix Ltd. (E), DePuy Synthes (B), Joint Solutions (B), Medtronic (C); Scientific Advisory Board/Other Office: ApiFix Ltd. (B); Grants: Atlantic Canada Opportunities Agency (I), DePuy Synthes (D), EOS Imaging (B), Scoliosis Research Society (B). DZ-R: Nothing to disclose. YF: Nothing to disclose. BSL: Stock Ownership: Paradigm Spine (D), Spine Search (E); Private Investments: Paradigm Spine (E); Consulting: DePuy Synthes (D), Zimmer Biomet (B), ApiFix (B), Unyq Align (B); Grants: DePuy Synthes to Setting Scoliosis Straight Foundation (D), John and Marcella Fox Fund Grant (B), OREF (C). YIA: Nothing to disclose. RRB: Consulting Fee of Honorarium: ApiFix (C), Other: ApiFix (A, stock options); Royalties: DePuy Synthes Spine (C), Globus Medical (C), SpineGuard (B), Thieme Medical Publishers (A); Stock Ownership: Abyrx (0), Electrocore (0), Medovex (0), Orthobond (0), SpineGuard (0), Wishbone Medical (0); Consulting: DePuy Synthes Spine (C), Globus Medical (C), SpineGuard (B), Wishbone Medical (B); Speaking and/or Teaching Arrangements: DePuy Synthes Spine (B), Globus Medical (C).